Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy

Hypertension. 2014 Sep;64(3):632-43. doi: 10.1161/HYPERTENSIONAHA.114.03315. Epub 2014 Jun 9.

Abstract

Preeclampsia is a pregnancy-related disorder characterized by hypertension with an unclear mechanism. Studies have shown endothelial dysfunction and increased endothelin-1 (ET-1) levels in hypertensive pregnancy (HTN-Preg). ET-1 activates endothelin receptor type-A in vascular smooth muscle to induce vasoconstriction, but the role of vasodilator endothelial endothelin receptor type-B (ETBR) in the changes in blood pressure (BP) and vascular function in HTN-Preg is unclear. To test whether downregulation of endothelial ETBR expression/activity plays a role in HTN-Preg, BP was measured in normal pregnancy (Norm-Preg) rats and rat model of HTN-Preg produced by reduction of uteroplacental perfusion pressure (RUPP), and mesenteric microvessels were isolated for measuring diameter, [Ca(2+)]i, and endothelin receptor type-A and ETBR levels. BP, ET-1- and potassium chloride-induced vasoconstriction, and [Ca(2+)]i were greater in RUPP than in Norm-Preg rats. Endothelium removal or microvessel treatment with ETBR antagonist BQ-788 enhanced ET-1 vasoconstriction and [Ca(2+)]i in Norm-Preg, but not RUPP, suggesting reduced vasodilator ETBR in HTN-Preg. The ET-1+endothelin receptor type-A antagonist BQ-123 and the ETBR agonists sarafotoxin 6c and IRL-1620 caused less vasorelaxation and nitrate/nitrite production in RUPP than in Norm-Preg. The nitric oxide synthase inhibitor Nω-nitro-L-arginine methyl ester reduced sarafotoxin 6c- and IRL-1620-induced relaxation in Norm-Preg but not in RUPP, supporting that ETBR-mediated nitric oxide pathway is compromised in RUPP. Reverse transcription polymerase chain reaction, Western blots, and immunohistochemistry revealed reduced endothelial ETBR expression in RUPP. Infusion of BQ-788 increased BP in Norm-Preg, and infusion of IRL-1620 reduced BP and ET-1 vasoconstriction and [Ca(2+)]i and enhanced ETBR-mediated vasorelaxation in RUPP. Thus, downregulation of microvascular vasodilator ETBR is a central mechanism in HTN-Preg, and increasing ETBR activity could be a target in managing preeclampsia.

Keywords: calcium; endothelins; hypertension; nitric oxide; pre-eclampsia.

MeSH terms

  • Animals
  • Blood Pressure / physiology
  • Down-Regulation
  • Endothelin B Receptor Antagonists
  • Endothelins / pharmacology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiology*
  • Female
  • Hypertension, Pregnancy-Induced / physiopathology*
  • Microvessels / physiopathology*
  • Oligopeptides / pharmacology
  • Peptide Fragments / pharmacology
  • Peptides, Cyclic / pharmacology
  • Piperidines / pharmacology
  • Pregnancy
  • Pregnancy, Animal / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Endothelin B / agonists
  • Receptor, Endothelin B / physiology*
  • Vasoconstriction / drug effects
  • Vasoconstriction / physiology
  • Vasodilation / drug effects
  • Vasodilation / physiology
  • Viper Venoms / pharmacology

Substances

  • Endothelin B Receptor Antagonists
  • Endothelins
  • Oligopeptides
  • Peptide Fragments
  • Peptides, Cyclic
  • Piperidines
  • Receptor, Endothelin B
  • Viper Venoms
  • sarafotoxins s6
  • sovateltide
  • BQ 788
  • cyclo(Trp-Asp-Pro-Val-Leu)